The iNanoBIT project focuses on developing highly sensitive nanotechnology-based imaging approaches allowing for examining transplanted cells and tissues (even the monitoring of the cellular morphology and survival characteristics of individual cells) in experiments with large animals and humans. The objective of these experiments will be to cure diabetes through the implantation of porcine pancreatic islets and human pluripotent stem cell-derived beta cells. Out of the total EU funding of the project 40% (i.e. EUR 2.8 billion) will go to three Hungarian members of the consortium, namely BioTalentum Kft. (EUR 1.3 million i.e. HUF 400 million), Mediso Kft. (EUR 795,000 i.e. HUF 246 million) and BBS Nanotechnológiai Kft. (EUR 710,000 i.e. HUF 220 million).
The EU_KP_16 call fostering the international consortium building of Hungarian partners is still open, entries are welcome.
Further information on the funded H2020 project: